Mechanotransductive receptor Piezo1 as a promising target in the treatment of fibrosis diseases
- PMID: 37900917
- PMCID: PMC10602816
- DOI: 10.3389/fmolb.2023.1270979
Mechanotransductive receptor Piezo1 as a promising target in the treatment of fibrosis diseases
Erratum in
-
Corrigendum: Mechanotransductive receptor Piezo1 as a promising target in the treatment of fibrosis diseases.Front Mol Biosci. 2024 May 16;11:1420585. doi: 10.3389/fmolb.2024.1420585. eCollection 2024. Front Mol Biosci. 2024. PMID: 38818356 Free PMC article.
Abstract
Fibrosis could happen in every organ, leading to organic malfunction and even organ failure, which poses a serious threat to global health. Early treatment of fibrosis has been reported to be the turning point, therefore, exploring potential correlates in the pathogenesis of fibrosis and how to reverse fibrosis has become a pressing issue. As a mechanism-sensitive cationic calcium channel, Piezo1 turns on in response to changes in the lipid bilayer of the plasma membrane. Piezo1 exerts multiple biological roles, including inhibition of inflammation, cytoskeletal stabilization, epithelial-mesenchymal transition, stromal stiffness, and immune cell mechanotransduction, interestingly enough. These processes are closely associated with the development of fibrotic diseases. Recent studies have shown that deletion or knockdown of Piezo1 attenuates the onset of fibrosis. Therefore, in this paper we comprehensively describe the biology of this gene, focusing on its potential relevance in pulmonary fibrosis, renal fibrosis, pancreatic fibrosis, and cardiac fibrosis diseases, except for the role of drugs (agonists), increased intracellular calcium and mechanical stress using this gene in alleviating fibrosis.
Keywords: Ca2+; Piezo1; Piezo2; fibrosis; therapeutic target.
Copyright © 2023 Xu, Huang, Cheng, Hu, Jiang, Wu, Peng and Hu.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures




Similar articles
-
Myeloid Piezo1 Deletion Protects Renal Fibrosis by Restraining Macrophage Infiltration and Activation.Hypertension. 2022 May;79(5):918-931. doi: 10.1161/HYPERTENSIONAHA.121.18750. Epub 2022 Mar 2. Hypertension. 2022. PMID: 35417225
-
Mechanotransductive Receptor Piezo1 as a Promising Target in the Treatment of Neurological Diseases.Curr Neuropharmacol. 2023;21(10):2030-2035. doi: 10.2174/1570159X20666220927103454. Curr Neuropharmacol. 2023. PMID: 36173070 Free PMC article.
-
Mechanosensitive Cation Channel Piezo1 Is Involved in Renal Fibrosis Induction.Int J Mol Sci. 2024 Jan 31;25(3):1718. doi: 10.3390/ijms25031718. Int J Mol Sci. 2024. PMID: 38338996 Free PMC article. Review.
-
Corrigendum: Mechanotransductive receptor Piezo1 as a promising target in the treatment of fibrosis diseases.Front Mol Biosci. 2024 May 16;11:1420585. doi: 10.3389/fmolb.2024.1420585. eCollection 2024. Front Mol Biosci. 2024. PMID: 38818356 Free PMC article.
-
PIEZO1-Related Physiological and Pathological Processes in CNS: Focus on the Gliomas.Cancers (Basel). 2023 Jan 31;15(3):883. doi: 10.3390/cancers15030883. Cancers (Basel). 2023. PMID: 36765838 Free PMC article. Review.
Cited by
-
Yoda1 Inhibits TGFβ-Induced Cardiac Fibroblast Activation via a BRD4-Dependent Pathway.Cells. 2025 Jul 4;14(13):1028. doi: 10.3390/cells14131028. Cells. 2025. PMID: 40643546 Free PMC article.
-
The role and mechanism of vascular wall cell ion channels in vascular fibrosis remodeling.Channels (Austin). 2024 Dec;18(1):2418128. doi: 10.1080/19336950.2024.2418128. Epub 2024 Oct 19. Channels (Austin). 2024. PMID: 39425532 Free PMC article. Review.
-
Matrix stiffening induces hepatocyte functional impairment and DNA damage via the Piezo1‒ERK1/2 signaling pathway.J Physiol Biochem. 2025 May;81(2):273-289. doi: 10.1007/s13105-025-01070-1. Epub 2025 Feb 25. J Physiol Biochem. 2025. PMID: 39994097
-
The modulating role of uniaxial straining in the IL-1β and TGF-β mediated inflammatory response of human primary ligamentocytes.Front Bioeng Biotechnol. 2024 Dec 10;12:1469238. doi: 10.3389/fbioe.2024.1469238. eCollection 2024. Front Bioeng Biotechnol. 2024. PMID: 39720167 Free PMC article.
-
PIEZO1 mediates periostin+ myofibroblast activation and pulmonary fibrosis in mice.J Clin Invest. 2025 Jun 2;135(11):e184158. doi: 10.1172/JCI184158. eCollection 2025 Jun 2. J Clin Invest. 2025. PMID: 40454481 Free PMC article.
References
-
- Andugulapati S. B., Gourishetti K., Tirunavalli S. K., Shaikh T. B., Sistla R. (2020). Biochanin-A ameliorates pulmonary fibrosis by suppressing the TGF-β mediated EMT, myofibroblasts differentiation and collagen deposition in in vitro and in vivo systems. Phytomedicine 78, 153298. 10.1016/j.phymed.2020.153298 - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous